We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZION:NASDAQZions Bancorporation N.A. Analysis

Data as of 2026-06-25 - not real-time

$68.30

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zions Bancorporation (ZION) is trading at $68.30, comfortably above its 20‑day SMA (64.70) and 50‑day SMA (63.04), confirming a bullish price trend. The 200‑day SMA (58.44) further underscores the long‑term upside bias. Momentum remains strong with a bullish MACD histogram (+0.31) and a bullish signal line crossover. However, the RSI 69.4 signals that the stock is approaching overbought territory, and the current price is just shy of the identified resistance at $69.08. Volume has been increasing, supporting the technical strength.
On the fundamentals side, ZION delivers a 10.2% revenue growth and a solid operating margin of 36%, translating to a healthy ROE of 14%. The trailing P/E 10.6 vs industry 16.9 positions the stock as a relative value play. The dividend yield 2.64% with a modest 27% payout ratio suggests sustainable cash returns. The updated fair‑value estimate of $68.75 and a consensus “Buy” rating (median target $68) imply that the market price is essentially fair‑valued with limited upside. Nevertheless, the 30‑day volatility of 21.8% and a beta near 1.0 indicate moderate price swings and sensitivity to broader market moves. Given the blend of growth, attractive yield, and reasonable valuation, the stock is best viewed as a balanced “blend” investment. Overall, the technical momentum, strong earnings profile, and sustainable dividend support a positive outlook, while the modest overbought signal and near‑term resistance suggest a cautious short‑term stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near resistance at $69.08
  • RSI indicating overbought conditions
  • increasing volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 10% revenue growth and strong operating margins
  • P/E well below industry average
  • sustainable dividend yield 2.64%

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • solid ROE of 14% and net cash position
  • fair valuation with limited downside risk
  • consistent dividend policy with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
Profit Margin28.36%
P/E Ratio10.6
ROE14.12%
ROA1.09%
P/B Ratio1.4
Op. Cash Flow$1.3B
Industry P/E16.9

Technical Analysis

TrendBullish
RSI69.4
Support$60.61
Resistance$69.08
MA 20$64.70
MA 50$63.04
MA 200$58.44
MACDBullish
VolumeIncreasing
Fear & Greed Index88.16

Valuation

Fair Value$133.49
Target Price$69.24
Upside/Downside1.37%
GradeFair
TypeBlend
Dividend Yield2.64%

Risk Assessment

Beta1.04
Volatility21.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.